Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Clear Cell Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
Pazopanib Hydrochloride Before Surgery in Treating Patients With Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Sunitinib Malate in Treating Patients With Previously Untreated Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Pazopanib Hydrochloride in Treating Patients With Stage IV Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of RO4929097 in Patients With Advanced Renal Cell Carcinoma That Have Failed Vascular Endothelial Growth Factor (VEGF)/Vascular Endothelial Growth Factor Receptor (VEGFR) Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Sunitinib Treatment for Metastatic Clear Cell Renal Cell Carcinoma (RCC)
- Status
- UNKNOWN
- Phase
- PHASE2
Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250
- Status
- COMPLETED
- Phase
- NA
Sunitinib Malate in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Tandutinib in Treating Patients Who Have Undergone Surgery for Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE3
Vorinostat and Bevacizumab in Treating Patients With Unresectable or Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
AZD2171 in Treating Patients With Refractory Metastatic Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses.
- Status
- COMPLETED
- Phase
- PHASE1
Bevacizumab, Erlotinib, and Imatinib in the Treatment of Advanced Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ixabepilone in Treating Patients With Metastatic, Recurrent, or Unresectable Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Sorafenib in Treating Patients Who Are Undergoing Surgery for Metastatic Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE2